Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
50%
Ph phase_4
1
25%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(4)

Detailed Status

Completed4

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 41 (33.3%)
N/A2 (66.7%)

Trials by Status

completed4100%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Total Versus Subtotal Abdominal Hysterectomy at Time of Abdominal Sacrocolpopexy

NCT04178473
completed

Clinical Follow up After Subtotal and Total Hysterectomy

NCT02166749
completedphase_4

Psychological Well-being, Recovery and Sexuality After Total and Subtotal Hysterectomy

NCT00876057
completednot_applicable

Total Versus Subtotal Hysterectomy:a Randomised, Prospective Multicentre Study of the Effect on Urinary, Sexual and Bowel Function

NCT00750035

Clinical Trials (4)

Showing 4 of 4 trials
NCT04178473Not Applicable

Total Versus Subtotal Abdominal Hysterectomy at Time of Abdominal Sacrocolpopexy

Completed
NCT02166749

Clinical Follow up After Subtotal and Total Hysterectomy

Completed
NCT00876057Phase 4

Psychological Well-being, Recovery and Sexuality After Total and Subtotal Hysterectomy

Completed
NCT00750035Not Applicable

Total Versus Subtotal Hysterectomy:a Randomised, Prospective Multicentre Study of the Effect on Urinary, Sexual and Bowel Function

Completed

All 4 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
4